← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Pacdna Llc
Natick, MA
$2,473,054
Total funding
2
Grants
Funding over time
peak $1.1M · FY2022–24$2M$1.5M$1M$500K$0
'22
'23
'24
Funding mix
By agency
NIH$2,473,054 · 1
DOD$0 · 1
By mechanism
R42$2,473,054 · 1
—$0 · 1
Investigators at Pacdna Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Molecular brush-conjugated antisense oligonucleotide as a pan-KRAS depletion agent$1,030,054
R42 · FY2023 · CA
Molecular brush-conjugated antisense oligonucleotide as a pan-KRAS depletion agent$988,000
R42 · FY2024 · CA
Molecular brush-conjugated antisense oligonucleotide as a pan-KRAS depletion agent$400,000
R42 · FY2022 · CA
Molecular brush-conjugated antisense oligonucleotide as a pan-KRAS depletion agent$55,000
R42 · FY2023 · CA
DEVELOPING MORE POTENT, DUAL EXON-SKIPPING OLIGONUCLEOTIDE THERAPEUTICS FOR DUCHENNE MUSCULAR DYSTROPHY.$0
· FY2024 · Defense Health Agency